# Edesa Biotech, Inc.: Form 8-K, filed Aug 9, 2024

- Company: [Edesa Biotech, Inc.](/companies/edsa.md) (CIK 1540159)
- Form: 8-K
- Filed: 2024-08-09
- Accepted by EDGAR: Aug 9, 2024, 16:30 ET
- Period: 2024-08-09
- Accession: 0001171843-24-004649
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1540159/000117184324004649/f8k_080924.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1540159/000117184324004649/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1540159/000117184324004649/f8k_080924.htm

Filed Aug 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001171843-24-004649. Last ingested by Listed: Nov 9, 2026, 17:01 ET. No prices; not investment advice.